“This case should be taken into consideration as blood donation policies are being crafted," the researchers wrote. 

Overall, the PCSK9 inhibitor was associated with a steady increase in coronary artery area and “significant coronary blood flow improvement.”

The project includes a new technology research center at Boston University and support for scientists around the world.

Results of the trial, which included more than 11,000 patients, were published in the New England Journal of Medicine.

Researchers tracked statin use among patients with peripheral artery disease, cerebrovascular disease and coronary heart disease.

When COVID-19 patients have an acute ischemic stroke (AIS), it can have an especially devastating effect.

The protein was designed to prevent cell death through the disruption of two specific Kv2.1 channels.

The analysis, published in Stroke, gathered data from two massive patient registries in China.